/YBGJ
YBGJ Stock - Yubo International Biotech Limited
Healthcare|Medical - Instruments & SuppliesOTC
$0.01+0.00%
+$0.00 (+0.00%) • Dec 19
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.14
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for YBGJ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.01 – $0.01
TARGET (TP)$0.02
STOP LOSS$0.01
RISK/REWARD1:1.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.62
52W High$0.18
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $3,470 | $104,283 | $1.24M | $1.35M | N/A |
| Gross Profit | $-209,275 | $52,652 | $820,647 | $1.24M | N/A |
| Gross Margin | -6031.0% | 50.5% | 65.9% | 91.6% | N/A |
| Operating Income | $-1,769,919 | $-1,205,223 | $-1,542,865 | $-711,798 | $-48,000 |
| Net Income | $-1,775,303 | $-1,204,765 | $-1,542,012 | $-711,804 | $-148,000 |
| Net Margin | -51161.5% | -1155.3% | -123.9% | -52.6% | N/A |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.13 |
Company Overview
Yubo International Biotech Limited, thorough its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is based in Beijing, China.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
YBGJBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q4 2024
EPS Surprise History
Q2 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q2 23
No data
Q2 23
No data
Q3 23
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | — | — | — |
Q3 2025 | Aug 13, 2025 | — | — | — | — |
Q2 2025 | May 14, 2025 | — | — | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 19, 2024 | — | — | — | — |
Q2 2024 | May 20, 2024 | — | — | — | — |
Q3 2023 | Aug 11, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.00 | — | — |
Q2 2023 | Apr 14, 2023 | — | $0.00 | — | — |
Q4 2022 | Nov 16, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 20, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 24, 2021 | — | $-0.00 | — | — |
Q1 2021 | Jan 19, 2021 | — | $-0.00 | — | — |
Q4 2020 | Oct 20, 2020 | — | $-0.00 | — | — |
Q3 2020 | Jul 20, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 24, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about YBGJ
What is YBGJ's current stock price?
Yubo International Biotech Limited (YBGJ) is currently trading at $0.01 per share. The stock has moved +0.00% today.
What is the analyst price target for YBGJ?
No analyst price targets are currently available for this stock.
What sector is Yubo International Biotech Limited in?
Yubo International Biotech Limited operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the OTC exchange.
What is YBGJ's market cap?
Yubo International Biotech Limited has a market capitalization of $0.00 billion, making it a small-cap company.
Does YBGJ pay dividends?
No, Yubo International Biotech Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANTCF
Aion Therapeutic Inc.
$0.00
Mkt Cap: $0.0B
BHNGF
Bhang Inc.
$0.00
Mkt Cap: $0.0B
EVIO
EVIO, Inc.
$0.00
Mkt Cap: $0.0B
HEMP
Hemp, Inc
$0.00
Mkt Cap: $0.0B
IONM
Assure Holdings Corp.
$0.00
Mkt Cap: $0.0B
IVRO
InVitro International
$0.09
Mkt Cap: $0.0B
KHRNF
Khiron Life Sciences Corp.
$0.00
Mkt Cap: $0.0B
MITI
Mitesco, Inc.
$0.09
Mkt Cap: $0.0B
MSIU
Medical Supply International USA, Inc.
$0.00
Mkt Cap: $0.0B
SHMN
SOHM, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to YBGJ for comparison